NYSE - Delayed Quote
USD
AbbVie Inc. (ABBV)
291.31
+3.07
(+1.07%)
At close: November 6 at 4:01:45 PM EST
291.31
0.00
(0.00%)
After hours: November 6 at 6:26:03 PM EST
Trade AbbVie on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutAbbVie’s latest results show 10.3% year-over-year revenue growth, led by Skyrizi and Rinvoq, while management raised its 2026 adjusted earnings outlook. The main forward risk is the Inflation Reduction Act’s government-set price for Vraylar in 2027, which could pressure growth as Humira and Imbruvica decline. AbbVie is also committing up to $1.37 billionto an early-stage inflammatory bowel disease program and expanding research operations in the United Kingdom.[1][2][3]
